Latest news with #SDT
Business Mayor
21-05-2025
- Business
- Business Mayor
Simmons & Simmons sees off cover-up allegations in decade-long dispute
International firm Simmons & Simmons has seen off an attempt by a prospective purchaser of a property owned by the Islamic Republic of Iran to bring it before the tribunal following a decade-long dispute. David Hinkel had been trying to buy a property in London and solicitors at Simmons & Simmons understood themselves to be instructed by an authorised representative of Iran, but the transaction did not proceed and it was never definitively determined whether the individual in question was authorised by Tehran or not. In 2018 Hinkel sued Simmons for wasted costs, alleging the firm had acted fraudulently, but the claim was summarily dismissed in 2020. He issued eight applications challenging a decision to refuse him permission to appeal, leading to Mr Justice Adam Johnson imposing an extended civil restraint order (ECRO) against him. The claimant later made two separate applications to the Solicitors Disciplinary Tribunal, leading to a series of decisions which ultimately concluded Simmons & Simmons had no case to answer. Hinkel appealed two of those decisions and the firm, as a respondent to each appeal, had submitted that Hinkel's applications were caught by the ECRO. This turned out to be incorrect and was 'promptly corrected'. Hinkel than applied to the SDT alleging that the firm had committed misconduct by making knowingly false statements. The SDT decided his application did not raise an arguable case. He appealed. In the High Court, Hinkel alleged the firm's submissions were made 'as part of an attempt to prevent the release of incriminating evidence'. He also accused the chair of the SDT, Angela Horne, of being 'riddled with the usual bias expected of her'. Dismissing the appeal, Mr Justice Henshaw said Hinkel's argument about Simmons & Simmons' motive 'makes little sense', pointing out he was able to obtain office copies of the filed documents he accused the firm of covering up. The judge added there was nothing which demonstrated Horne was biased. 'There is no merit in this appeal. The SDT's decision that no prima facie case had been put forward against the respondents was correct. The appeal must be dismissed', Henshaw said.
Associated Press
15-05-2025
- Business
- Associated Press
Alpheus Medical Raises $52M in Series B Round to Advance Groundbreaking Glioblastoma Therapy
Funding will support a randomized Phase 2B study of the novel sonodynamic therapy in patients with newly diagnosed glioblastoma CHANHASSEN, Minn., May 15, 2025 /PRNewswire/ -- Alpheus Medical, Inc., a private, clinical-stage oncology company pioneering sonodynamic therapy (SDT) for the treatment of solid body cancers, today announced the closing of an oversubscribed $52 million Series B financing round. The funds will support a Phase 2B randomized controlled trial (RCT) evaluating the efficacy of SDT in patients with newly diagnosed glioblastoma (GBM) – one of the most aggressive and deadly forms of brain cancer. Backed by leading healthcare investors, the round was co-led by HealthQuest Capital and Samsara BioCapital with participation from existing investors OrbiMed and Action Potential Venture Capital. In addition, venture investors committed to transforming cancer care participated, including BrightEdge, the impact investment and innovation arm of the American Cancer Society, the Brain Tumor Investment Fund, a subsidiary of the National Brain Tumor Society, and Sontag Innovation Fund, a subsidiary of The Sontag Foundation. 'The complex and diffuse nature of glioblastomas has long hindered therapeutic innovation,' said Conrad Wang M.D., Partner at HealthQuest Capital. 'Alpheus' sonodynamic therapy represents a novel, non-invasive whole brain approach with compelling early data. This investment reflects our commitment to advancing transformative technologies that seek to fill critical gaps in patient unmet needs.' Alpheus' platform delivers non-thermal, tumor-selective therapy activated by low-intensity diffuse ultrasound (LIDU™) with oral 5-aminolevulinic acid (5-ALA). Without the need for imaging or sedation, this combination selectively targets and destroys cancer cells across the entire brain hemisphere. This novel treatment option is performed in an outpatient setting. Promising early results from two studies highlight the potential of SDT therapy in both newly diagnosed and recurrent glioblastoma patients. 'This investment is a key inflection point for Alpheus and the glioblastoma community – advancing sonodynamic therapy from promise to clinical validation,' commented Vijay Agarwal, MD, FAANS, FCNS, President and CEO of Alpheus Medical. 'With this support, we are poised to generate pivotal evidence that could help establish a new standard of care for newly diagnosed brain tumors.' About Alpheus Medical, Inc. Alpheus Medical is a private, clinical-stage oncology company developing a groundbreaking, non-invasive treatment for solid tumors utilizing sonodynamic therapy (SDT). Its proprietary platform combines Low-Intensity Diffuse Ultrasound (LIDU™) with oral 5-aminolevulinic acid (5-ALA), a sensitizing agent that selectively accumulates in tumor cells. This targeted approach aims to destroy cancer cells while sparing healthy tissue. Alpheus collaborates with global leaders in neuro-oncology and is supported by top healthcare investors and the venture vehicles of nonprofit organizations focused on cancer. Learn more at About HealthQuest Capital HealthQuest Capital is a private asset firm that provides capital to transformative healthcare companies. HealthQuest Capital focuses on commercial prospects that drive enhanced patient outcomes and elevate the efficiency of healthcare delivery. With approximately $2 billion in capital under management, the firm focuses on fostering innovation across the healthcare spectrum, including medical technologies, diagnostics, digital health, and innovative services. The HealthQuest Capital team combines decades of investing experience with domain expertise in the various aspects of the healthcare industry. For more information, visit About Samsara BioCapital Founded in 2017, Samsara BioCapital is a leading biotech investment firm focused on identifying opportunities across public and private markets. Samsara invests across the full spectrum from early-stage start-up to late-stage clinical assets with a focus on companies that will have a significant impact on patients and address high unmet medical needs. Samsara works with entrepreneurs and top-tier management teams that they believe will have a meaningful impact on innovative therapeutics. The Samsara team has deep expertise in biotech with significant experience working together prior to founding the firm. The team is led by Srinivas Akkaraju, who has over twenty-two years of industry experience and has an MD and a PhD in Immunology from Stanford University. Media Contact Carla Benigni [email protected] View original content to download multimedia: SOURCE Alpheus Medical
Time of India
21-04-2025
- Entertainment
- Time of India
BTS' V praised by fellow soldier for winning Military Awards despite injuries
twitter A fellow soldier who served alongside BTS member Kim Taehyung, also known as V, has shared a heartfelt tribute online, describing how the singer became a source of motivation during their time in the military. The post has touched the hearts of BTS fans, also known as ARMY, and has gone viral on social media. The soldier, who has recently completed his military service, uploaded several group photos with V, including pictures from training and casual moments like walks, meals, and time spent together in the forest. Along with these photos, he shared a moving handwritten message describing V's inspiring dedication—even when he was injured. According to the soldier, V stood out during training despite not being in the best physical condition. He mentioned that his own body was in pain, especially his shoulders and thighs, but seeing V achieve so much gave him the motivation to keep going. V reportedly took first place in full-arm shooting and winter city training, and also received the Military Police Exemplary Award—all while dealing with injuries. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Trade Bitcoin & Ethereum – No Wallet Needed! IC Markets Start Now Undo One of the most memorable experiences for the soldier was when they completed their final physical fitness test together. He recalled running a 3-kilometer race side by side with V, both of them shouting 'Fighting!' to encourage each other until they reached the finish line. That memory, he said, was especially meaningful. The soldier explained that watching V's passion and consistency gave him the strength to chase his own dream of becoming a rehabilitation therapist. He added that his military experience became more enjoyable because of V's presence and support. Calling V his 'brother,' he promised to continue working hard without giving up, just like V had shown him. Fans responded warmly to the post, expressing deep gratitude for the photos and the kind words about V. Many commented how proud they were of him, while others thanked the soldier for sharing such personal and inspiring memories. One fan wrote, 'We're truly proud of him and the entire SDT team. Please stay safe and healthy.' Another added, 'Thank you for being good friends to our Taehyungie.' Kim Taehyung is currently serving in the Special Duty Team (SDT) of the South Korean military . Along with fellow BTS members RM, Jungkook, Jimin, and Suga, he is expected to complete his service and return to civilian life in June 2025.
Gulf News
21-04-2025
- Entertainment
- Gulf News
BTS' V's fellow soldier reveals how the injured star kept winning military awards, despite pain: 'Truly inspiring'
BTS ARMYs were overjoyed, after a fellow Special Duty Team (SDT) soldier who served alongside BTS' Kim Taehyun g, or V, shared a series of touching group photos featuring Taehyung—and paired them with a deeply heartfelt note. The soldier, who has just completed his military service, revealed how V's dedication pushed him through some of the toughest moments in his own military journey. From topping the charts in full-arm shooting and winter city training to receiving a Military Police Exemplary Award despite being injured, V's efforts seems to have clearly left a mark. A rare glimpse into V's low-key military life One photo shows V in the forest, possibly mid-training. In other photos, he is grabbing brunch, enjoying walks or just enjoying the moments of camaraderie. Considering that his discharge is inching closer, fans are more excited than ever. A handwritten message accompanying the post read, 'My body, including my shoulders and thighs, wasn't feeling well overall, but I got a lot of motivation when I saw you receiving 1st place in full-arm shooting, 1st place in winter city training and shooting, and even receiving the Military Police Exemplary Award despite being injured,' he wrote and added, 'Watching all that was truly inspiring.' Another memory was during heir final physical fitness test, where they ran 3 km side by side, yelling 'Fighting!' and pushing each other to the finish line. 'That moment was just awesome,' the soldier recalled. ARMYs react Owing V's consistency and passion, the soldier found the strength to keep pursuing his dream of becoming a rehabilitation therapist. 'My military life was more enjoyable because of my brother,' he wrote. 'I'll keep going steady, not giving up—just like you, Hyung. Always stay healthy.' The post instantly lit up on social media. 'There are many of us who thank you from the bottom of our hearts for these photos, but above all, for the kind words you dedicated to our Taehyung,' one fan commented. Another added, 'We're truly proud of him and the entire SDT team. Please stay safe and healthy.' A third simply said, 'Thank you for being good friends to our Taehyungie.'
Yahoo
25-03-2025
- Business
- Yahoo
Giving a colleague a ‘rude' nickname could cost workers thousands
Office staff who give rude nicknames to colleagues could have to pay thousands following a groundbreaking ruling. Leo Foster, a senior in-house solicitor, has been fined £15,000 and ordered to pay £16,000 costs for referring to co-workers in his team as 'Jabba the Hutt', 'Pol Pot', 'The Idiot', 'Mad Paul' and 'The Twittering Fool'. Mr Foster, who worked at multinational bank BNP Paribas in London, also branded a colleague 'Hu She', a solicitors disciplinary tribunal heard. She pronounced her name 'Who-ee', the hearing was told, but Foster was inspired by the 'Who he' joke in Private Eye, the satirical magazine. Foster admitted using 'inappropriate, unprofessional and rude nicknames' on 'numerous occasions' over the course of many months - including in emails. He accepted that his colleagues did not consent to the use of the nicknames, but insisted that he never had any racist intention towards his co-worker with the Chinese name. The Solicitors Regulation Authority took action after allegations against Mr Foster emerged in business newspaper City A.M. On other occasions, he described bosses at the bank as 'c---s' and questioned whether one was autistic, the hearing heard. In an email, Mr Foster wrote: 'Who the f--- is this?' while in another he said: 'Looks like a bunch of c---s.' The Law Society reported: 'Foster's lawyer told the SDT he was extremely apologetic and had not intended to cause anyone offence or hurt.' It added: 'The misconduct had taken place during a stressful time and was a small fraction of the correspondence he sent.' The tribunal heard Foster had been 'disgruntled with management changes' at the bank. In its judgement, the SDT said: 'Mr Foster had found the changes to the working environment difficult, but he had failed to handle this with the standards expected of a solicitor of his experience and standing.' The hearing was told that Foster had 'negotiated an exit from the bank', quietly retiring in 2022. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
